Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with pseudomyxoma peritonei or peritoneal metastases of colorectal carcinoma; positive first experiences in the Netherlands Cancer Institute;Hypertherme intraperitoneale chemotherapie (HIPEC) bij patienten met pseudomyxoma peritonei of peritoneummetastasen van colorectaal carcinoom; gunstige eerste ervaringen in het Nederlands Kanker Instituut

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 37, 1999, Pages 1863-1868

  Zoetmulder, F A N ^a   Van Der Vange, N ^a   Witkamp, A J ^a   Kaag, M M ^a   Boot, H ^a   Beijnen, J H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN;

ADVERSE DRUG REACTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DOSE RESPONSE; FOLLOW UP; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MAXIMUM PERMISSIBLE DOSE; PERITONEUM LAVAGE; PERITONEUM METASTASIS; PERITONEUM PSEUDOMYXOMA; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERTHERMIA, INDUCED; MITOMYCIN; NETHERLANDS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033546914     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sugarbaker PH. Observation concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management, 1st ed. Dordrecht: Kluwer; 1996.
2. Averbach AM, Sugarbaker PH. Recurrent intraabdominal cancer causing intestinal obstruction: Washington Hospital Center experience with 42 patients managed by surgery and intraperitoneal chemotherapy. Cancer Treat Res 1996;81:133-47.
3. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
4. Benson 3rd AB. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results. Oncology (Huntingt) 1998;12(10 Suppl 7):28-34.
5. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992;10: 904-11.
6. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-32.
7. Sugarbaker PH, Graves T, Bruijn EA de, Cunliffe WJ, Mullins RE, Hull WE, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990; 50:5790-4.
8. Goethem AR van, Beijnen JH, Coevorden F van, Kaag MM, Slooten GW van, Zoetmulder FAN. Cytoreductie en hypertherme intra-peritoneale chemotherapie. Ned Tijdschr Heelkd 1997;6:107-11.
9. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221: 29-42.
10. Baretta G, Cummings J, Jodrell D. Colon and rectal carcinomas. In: Baretta G, Cummings J, Jodrell D, editors. Mitomycin C. Forty years' clinical experience, 1st ed. Turijn: Edizione Minerva Medica; 1997. p. 87-97.
11. Urano M. Thermochemotherapy: from in vitro and in vivo experiments to potential clinical application. In: Urano M, Douple E, editors. Hyperthermia and oncology. Vol 4. Chemopotention by hyperthermia. Zeist: VSP; 1994. p. 87-97.
12. Kawara K, Kano E. Enhancement of cytotoxic effects of chemotherapeutic agents in vitro and in vivo antibiotics. Hyperthermia and Oncology 1994;4:55-69.
13. McClay EF, Howell SB. A review: intraperitoneal cisplatin in the management of patients with ovarian cancer. Gynecol Oncol 1990; 36:1-6.
14. Howell SB, Zimm S, Markman M, Abramson IS, Cleary S. Lucas WE, et al. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J Clin Oncol 1987;5:1607-12.
15. Los G, Vugt MJH van, Pinedo HM. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994;69:235-41.
16. Benedetti-Panici P, Maneschi F, Scambia G, Cutillo G, Greggi S, Mancuso S. The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma. Obstet Gynecol 1996;87:532-8.
17. Eisenkop SM, Nalick RH, Teng NN. Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991;78(5 Pt 1):879-85.
18. Adelson MD. Cytoreduction of diaphragmatic metastases using the Cavitron Ultrasonic Surgical Aspirator. Gynecol Oncol 1991;41: 220-2.
19. Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989;27:621-7.
20. Dahl O. Mechanisms of thermal enhancement of chemotherapeutic toxicity. In: Urano M, Douple E, editors. Hyperthermia and oncology. Vol 4. Chemopotention by hyperthermia. Zeist: VSP; 1994. p. 9-28.
21. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Blond R, Chang D, et al. Pseudomyxoma peritonei syndrome. Adv Surg 1996; 30:233-80.
22. Sugarbaker PH. Pseudomyxoma peritonei. Cancer Treat Res 1996; 81:105-19.